IFN-gamma reverses IL-4 inhibition of fetal thymus growth in organ culture

J Immunol. 1991 Jul 1;147(1):50-4.

Abstract

IL-4 is known to inhibit the growth and differentiation of 14-day-old fetal mouse thymus in organ culture. Here we report that IFN-gamma reverses this IL-4-mediated growth inhibition. Thymus lobes from 14-day-old fetuses were cultured for 12 days in medium containing 100 IU/ml rIL-4 either in the absence or presence of rIFN-gamma (100 to 1000 IU/ml). After culture, the cell yields and the absolute numbers and frequencies of the major subpopulations according the coordinate expression of CD4 and CD8 were estimated. IL-4 treatment alone was found to result in a seven-fold decrease in cell yield and an almost complete absence of the CD4+CD8+ subpopulation. Addition of IFN-gamma reversed IL-4-mediated inhibition in a dose-dependent fashion, with an optimal dose ranging from 200 to 500 IU/ml. IFN-gamma exerted this effect only when added within the first 48 h of initiating the culture. The specificity of the reversal effect was ascertained by neutralization of the effect by a neutralizing anti-IFN-gamma mAb and by lack of activity of human IFN-gamma. In the absence of IL-4, IFN-gamma had a growth-promoting effect as evident from a threefold increase in cell numbers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation / drug effects
  • Dose-Response Relationship, Drug
  • Flow Cytometry
  • Interferon-gamma / pharmacology*
  • Interleukin-4 / antagonists & inhibitors*
  • Mice
  • Mice, Inbred BALB C
  • Organ Culture Techniques
  • Receptors, Interleukin-2 / metabolism
  • Recombinant Proteins
  • T-Lymphocyte Subsets / cytology
  • Thymus Gland / cytology
  • Thymus Gland / embryology
  • Thymus Gland / growth & development*

Substances

  • Receptors, Interleukin-2
  • Recombinant Proteins
  • Interleukin-4
  • Interferon-gamma